.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Chubb
Fish and Richardson
Boehringer Ingelheim
Novartis
Baxter
Express Scripts
Moodys
Cantor Fitzgerald
Harvard Business School

Generated: November 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for tradename: PARLODEL

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDAValidus Pharmaceuticals LLC30698-201-01100 CAPSULE, GELATIN COATED in 1 BOTTLE (30698-201-01)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDAValidus Pharmaceuticals LLC30698-201-3030 CAPSULE, GELATIN COATED in 1 BOTTLE (30698-201-30)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDAValidus Pharmaceuticals LLC30698-202-01100 TABLET in 1 BOTTLE (30698-202-01)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDAValidus Pharmaceuticals LLC30698-202-3030 TABLET in 1 BOTTLE (30698-202-30)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDARanbaxy Pharmaceuticals Inc.63304-158-01100 CAPSULE in 1 BOTTLE (63304-158-01)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDARanbaxy Pharmaceuticals Inc.63304-158-3030 CAPSULE in 1 BOTTLE (63304-158-30)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDARanbaxy Pharmaceuticals Inc.63304-962-01100 TABLET in 1 BOTTLE (63304-962-01)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962NDARanbaxy Pharmaceuticals Inc.63304-962-3030 TABLET in 1 BOTTLE (63304-962-30)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
TABLET;ORAL017962NDAValidus Pharmaceuticals LLC30698-201-01100 CAPSULE, GELATIN COATED in 1 BOTTLE (30698-201-01)
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
TABLET;ORAL017962NDAValidus Pharmaceuticals LLC30698-201-3030 CAPSULE, GELATIN COATED in 1 BOTTLE (30698-201-30)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Medtronic
Colorcon
Citi
Cipla
Chubb
US Department of Justice
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot